Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of α-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma

被引:81
作者
Hayashi, K
Kumada, T
Nakano, S
Takeda, I
Sugiyama, K
Kiriyama, S
Sone, Y
Miyata, A
Shimizu, H
Satomura, S
机构
[1] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu 5030864, Japan
[2] Wako Pure Chem Ind Ltd, Osaka Res Labs, Amagasaki, Hyogo, Japan
关键词
D O I
10.1016/S0002-9270(99)00434-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3%) is a recently described marker of hepatocellular carcinoma (HCC), and its usefulness has been demonstrated in many studies. WE: evaluated the use fulness of serial measurement of AFP-L3% as a marker of prognosis and recurrence after treatment of small HCC. METHODS: AFP-L3% was measured before and after initial treatment in 60 patients with small HCC (maxi diameter less than or equal to 2 cm). AFP-L3% was taken as the ratio of AFP-L3 to total AFP and multiplied by 100%, and levels greater than or equal to 10% were considered positive. Outcomes and recurrence were compared between patients AFP-L3%-negative after initial treatment (Group A, n = 43) and patients who were AFP-L3%-positive after initial treatment (Group B,n = 17). RESULTS: Before treatment, AFP-L3% was positive in 14 (23.3%) of the 60 patients. The cumulative survival rate of Group A was significantly longer (p = 0.0091) than that of Group B. The recurrence race was significantly higher in Group B (p = 0.0104) than in Group A. When recurrence was limited to intrahepatic metastasis, the recurrence rate was significantly higher in Group B (p = 0.0064). However, the recurrence race of multicentric occurrence did not differ significantly between Groups A and B, CONCLUSIONS: Measurement of AFP-L3% after treatment may be useful for understanding prognosis and recurrence of HCC. (C) 1999 by Am. Coil. of Gastroenterology.
引用
收藏
页码:3028 / 3033
页数:6
相关论文
共 35 条
[1]   RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA [J].
ADACHI, E ;
MAEDA, T ;
MATSUMATA, T ;
SHIRABE, K ;
KINUKAWA, N ;
SUGIMACHI, K ;
TSUNEYOSHI, M .
GASTROENTEROLOGY, 1995, 108 (03) :768-775
[2]  
ALPERT E, 1978, GASTROENTEROLOGY, V74, P856
[3]   FUCOSYLATION INDEX OF ALPHA-FETOPROTEIN, A POSSIBLE AID IN THE EARLY RECOGNITION OF HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH CIRRHOSIS [J].
AOYAGI, Y ;
SAITOH, A ;
SUZUKI, Y ;
IGARASHI, K ;
OGURO, M ;
YOKOTA, T ;
MORI, S ;
SUDA, T ;
ISEMURA, M ;
ASAKURA, H .
HEPATOLOGY, 1993, 17 (01) :50-52
[4]  
BLOOMER JR, 1975, JAMA-J AM MED ASSOC, V233, P39
[5]  
Child CG III, 1964, LIVER PORTAL HYPERTE, P49
[6]  
Cox DR, 1972, J ROYAL STAT SOC B, V34, P87
[7]   PERCUTANEOUS ETHANOL INJECTION FOR THE TREATMENT OF SMALL HEPATOCELLULAR-CARCINOMA - STUDY OF 95 PATIENTS [J].
EBARA, M ;
OHTO, M ;
SUGIURA, N ;
KITA, K ;
YOSHIKAWA, M ;
OKUDA, K ;
KONDO, F ;
KONDO, Y .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1990, 5 (06) :616-626
[8]  
IKEDA K, 1993, HEPATOLOGY, V17, P1003, DOI 10.1002/hep.1840170610
[9]   IMAGING DIAGNOSIS OF SMALL HEPATOCELLULAR-CARCINOMA [J].
IKEDA, K ;
SAITOH, S ;
KOIDA, I ;
TSUBOTA, A ;
ARASE, Y ;
CHAYAMA, K ;
KUMADA, H .
HEPATOLOGY, 1994, 20 (01) :82-87
[10]   PROGNOSTIC FACTORS OF HEPATOCELLULAR-CARCINOMA IN PATIENTS UNDERGOING HEPATIC RESECTION [J].
IZUMI, R ;
SHIMIZU, K ;
II, T ;
YAGI, M ;
MATSUI, O ;
NONOMURA, A ;
MIYAZAKI, I .
GASTROENTEROLOGY, 1994, 106 (03) :720-727